Immuneering (IMRX) Gross Profit (2020 - 2022)
Immuneering (IMRX) recorded quarterly Gross Profit of $455.0 in Q4 2022, down 97.61% quarter-over-quarter from $19037.0 in Q3 2022, and up 102.74% on a YoY basis from $224.43 in Q4 2021.
Immuneering (IMRX) Gross Profit (2020 - 2022) Analysis & Trends
Immuneering's Gross Profit history runs 3 years deep, the most recent figure standing at $455.0 for Q4 2022.
- In Q4 2022, Gross Profit rose 102.74% year-over-year to $455.0; the TTM figure through Sep 2023 stood at $455.0 (down 99.68% YoY), while the FY2022 annual figure was $158830.0, down 82.86% from the prior year.
- Gross Profit was $455.0 for Q4 2022 at Immuneering, down from $19037.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $367568.0 in Q3 2020 to a low of -$16630.0 in Q4 2021.
- Historically, Gross Profit has averaged $171718.7 across 3 years, with a median of $191847.0 in 2020.
- The sharpest annual moves came in 2021 and 2022: Gross Profit tumbled 108.67% in 2021, then jumped 102.74% in 2022.
- A 3-year view of Gross Profit shows it stood at $191847.0 in 2020, then tumbled by 108.67% to -$16630.0 in 2021, then surged by 102.74% to $455.0 in 2022.
- The last three Gross Profit figures came in at $455.0 (Q4 2022), $19037.0 (Q3 2022), and $46486.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 455.00 |
| Dec 31, 2022 | 455.00 |
| Sep 30, 2022 | 19,037.00 |
| Sep 30, 2022 | 19,037.00 |
| Jun 30, 2022 | 46,486.00 |
| Jun 30, 2022 | 46,486.00 |
| Mar 31, 2022 | 92,852.00 |
| Mar 31, 2022 | 92,852.00 |
| Dec 31, 2021 | -16,630.00 |
| Dec 31, 2021 | -16,630.00 |
| Sep 30, 2021 | 263,042.00 |
| Sep 30, 2021 | 263,042.00 |
| Jun 30, 2021 | 341,439.00 |
| Jun 30, 2021 | 341,439.00 |
| Mar 31, 2021 | 339,037.00 |
| Mar 31, 2021 | 339,037.00 |
| Dec 31, 2020 | 191,847.00 |
| Dec 31, 2020 | 191,847.00 |
| Sep 30, 2020 | 367,568.00 |
| Sep 30, 2020 | 367,568.00 |